Cours Innovus Pharmaceuticals Inc OTC Bulletin Board
Actions
US45778V1061
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32% | 815 Md | |
-6,75% | 352 Md | |
+13,56% | 314 Md | |
+10,68% | 303 Md | |
+16,57% | 242 Md | |
+2,04% | 224 Md | |
+13,31% | 218 Md | |
+8,48% | 168 Md | |
-2,81% | 159 Md |